期刊文献+

34例神经精神狼疮患者的临床资料分析 被引量:3

Clinical analysis of 34 patients with neuropsychiatric systemic lupus erythematosus
暂未订购
导出
摘要 目的:对神经精神狼疮(NPSLE)患者的临床表现、治疗及预后进行总结。方法:对34例确诊为NPSLE住院患者的临床表现、影像学资料、实验室指标、治疗及预后等临床资料进行回顾性分析。结果:同期住院诊断SLE共818例,诊断NPSLE34例,发病率为4.16%。NPSLE首发症状最常见的是狼疮性头痛(24.2%)、脑血管病变(22.3%),发热(97.1%)及新发皮疹(61.8%)为常见的伴随症状。根据SLEDAI评分,34例患者中76.5%患者处于疾病重度活动期(评分≥15)。结论:NPSLE临床表现多样,2种及以上临床亚型并存者多见。首发症状以狼疮性头痛最常见。颅脑影像学检查在NPSLE的诊断中具有重要意义。 Objective : To summarize the clinical manifestation, treatments and prognosis of patients with neuropsychiatric systemic lupus erythematosus (NPSLE) . Methods: Clinical manifestation, imaging data, laboratory indexes, treatments and prognosis were analyzed retrospectively in 34 patients diagnosed as NPSLE. Results: Among 818 cases with SLE, 34 cases were diagnosed with NPSLE (4.16%). The most frequent initial manifestations were headache (24.2%) and cerebrovascular symptoms and signs (22.3%) ; fever (97.1%) and newly emerging rash (61.8%) were the most common accompanied general symptoms. According to SLEDAI score, 76.5% of NPSLE patients were in severe active stage (SLEDAI score ≥ 15 ). Conclusion: The symptoms of NPSLE were heterogeneous. It was common that NPSLE present two or more clinical subtypes at the same time. Cerebral imaging examination was important for the diagnosis of NPSLE.
出处 《内科急危重症杂志》 2012年第6期343-345,共3页 Journal of Critical Care In Internal Medicine
关键词 系统性红斑狼疮 神经精神狼疮 临床分型 临床表现 治疗 Systemic lupus erythematosus Neuropsychiatric systemic lupus erythematosus Clinical classification Clinical manifestation Treatment
  • 相关文献

参考文献8

二级参考文献36

  • 1张奉春,董怡,赵玉华,林禾,姜泉,赵杰.系统性红斑狼疮中枢神经系统病变的诊断及治疗[J].北京医学,1994,16(5):277-280. 被引量:23
  • 2[1]Mitchell I,Webb M,Hughes R,et al.Cerebral lupus.Lancet,1994,343 (8897):579-582.
  • 3[2]Eustace S,Hutchinson M,Bresnihan B.Acute cerebrovascular episodes in systemic lupus erythematosus.Q J Med,1991,80 (293):739-750.
  • 4Hochberg MC.Updating the American Collage of Rheumatology revised criteria for the classification of systemic lupus erythematosus.Arthritis Rheum,1997,40:1725.
  • 5ACR Ad Hoc Committee on Neuropsychiatric Lupus Nomenclature.The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes.Arthritis Rheum,1999,42:599-608.
  • 6Bonbardier C,Gladman DD,Urowitz MB,et al.Derivation of the SLEDAI.A disease activity index for lupus patients.The Committee on Prognosis Studies in SLE.Arthritis Rheum,1992,35:630-640.
  • 7Mok CC,Lau CS,Wong RWS.Neuropsychiatric manifestations and their clinical associations in southern Chinese patients with systemic lupus erythematosus.J Rheumatol,2001,28:766-771.
  • 8Sanna G,Bertolaccini ML,Cuadrado MJ,et al.Neuropsychiatric manifestations in systemic lupus erythematosus:Prevalence and association with antiphospholipid antibodies.J Rheumatol,2003,30:985-992.
  • 9Valesini G,Priori R,Francia A,et al.Central nervous system involvement in systemic lupus erythematosus:a new therapeutic approach with intrathecal dexamethasone and methotremate.Springer Semin Immunopathol,1994,16:313-321.
  • 10Jennekens FG,Kater L.The central nervous system in systemic lupus erythematosus.Part 2.Pathogenetic mechanisms of clinical syndromes:a literature investigation.Rheumatology (Oxford),2002,41:619-630.

共引文献43

同被引文献16

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部